PHOTOBIOMODULATION MARKET Challenges and Opportunities

One of the key challenges in the global photobiomodulation market is the high cost of photobiomodulation devices. These devices use lasers or LED lights to treat pain and various medical conditions. However, the capital cost of setting up the required laser equipment for treatment is substantial. Commonly used wavelengths such as 635nm, 670nm, and 830nm also require expensive specialized laser diodes or LED modules. Additional costs are incurred towards regular servicing and safety certifications for these systems.

Market Opportunity - Advancements in Technology and Product Innovation

The photobiomodulation market is poised to experience significant growth due to ongoing advancements in underlying technology and rising product innovation. Manufacturers are launching portable and handheld photobiomodulation devices that are more affordable and accessible for home use and small clinics. For instance, in June 2023, Lumaflex, a health tech company, launched the Lumaflex Body Pro, an U.S. FDA (Food and Drug Administration Class 2-certified red light therapy device. Popular among bodybuilders and MMA athletes, it offers advanced muscle recovery solutions.